Aprogen's Subsidiary Aptn to Raise 3.5B KRW
에이프로젠
007460
Signal Score
Historical Avg Return (5d)
+0.31%
Data Coverage
100%n=2386
Risk-adjusted indicator based on 2386 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New Shares Issued: 3,500,000 Shares
- • Issue Price per Share: 1,000 KRW
- • Total Funding: 3,500,000,000 KRW
- • Pre-issuance Shares Outstanding: 19,658,914 Shares
- • Dilution Rate: 17.8%
AI Analysis Summary
Aprogen's subsidiary, Aptn Inc., decided on a third-party allotment paid-in capital increase, issuing 3,500,000 common shares at 1,000 KRW per share, raising a total of 3.5 billion KRW. The funds are earmarked for acquiring securities of other corporations, specifically for investment in GPCR Co., Ltd. for new drug R&D. With 19,658,914 shares outstanding before the issuance, this represents a dilution of approximately 17.8% for existing shareholders. The issue price of 1,000 KRW is above the calculated reference price of 784.62 KRW, but equal to the par value. All new shares will be subject to a one-year lock-up period. While the funding supports new business initiatives, the significant dilution could negatively impact existing shareholder value.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.